BCMA-targeted CAR-T cell therapy for multiple myeloma

The present application provides methods of treating a subject suffering from multiple myeloma with a suspension of chidamidyl olarenide. The present application also provides a pharmaceutical product containing the suspension of the chidazino-olarenide, an instruction for use of the suspension of t...

Full description

Saved in:
Bibliographic Details
Main Authors FAN XIAOHU, SCHECHTER JORDAN, HIRSCHMANN MICHAEL, PACAUD, LYDIA
Format Patent
LanguageChinese
English
Published 05.11.2024
Subjects
Online AccessGet full text

Cover

More Information
Summary:The present application provides methods of treating a subject suffering from multiple myeloma with a suspension of chidamidyl olarenide. The present application also provides a pharmaceutical product containing the suspension of the chidazino-olarenide, an instruction for use of the suspension of the chidazino-olarenide, and a method for selling a pharmaceutical product containing a suspension of the chidazino-olarenide. 本申请提供了用西达基奥仑赛混悬液治疗患有多发性骨髓瘤的受试者的方法。本申请还提供了含有西达基奥仑赛混悬液的药物产品、西达基奥仑赛混悬液的使用说明书以及用于销售含有西达基奥仑赛混悬液的药物产品的方法。
Bibliography:Application Number: CN20238022977